Erlotinib intermediates manufacturer
CAS No.:1009119-65-6
Other Names:Daclatasvir
MF:C40H52Cl2N8O6
Place of Origin: China (Mainland)
Type:Vitamins, Amino Acids and Coenzymes
Grade Standard:Medicine Grade
Purity:99%min
Color:white
Product Name:Daclatasvir
Grade:Medical Grade
Application:Health-care Products
Assay:99%
CAS:1009119-65-6
Shelf life:2 Years
Certificate:COA
Appearance:white powder
Supply Ability
Supply Ability:
4000 Kilogram/Kilograms per Month
Packaging & Delivery
Packaging Details
25kgs packaging Fiber
drum outside and plastic bag inside 1-25kgs packaging aluminium bag outside and
double plastic bag inside.
Delivery Detail: within 3 days when get the payment
Port
Any port in china
Lead Time :
3 days when get the payment
Introduction:
Daclatasvir is a drug for the treatment of hepatitis C (HCV).Daclatasvir inhibits the HCV nonstructural protein NS5A.Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA.
Certificate of Analysis
|
Tests |
Specifications |
Results |
|
Appearence |
White crystalline powder |
Complies |
|
Loss on Drying |
≤0.5% |
0.06% |
|
Residue on Ignition |
≤0.2% |
Complies |
|
Related substances |
Any impurity NMT 0.1% |
0.03% |
|
Sulphated Ash |
≤0.2% |
0.03% |
|
Heavy metals |
≤20PPM |
Complies |
|
Single impurity |
NMT 0.5% |
0.4% |
|
Total impurities |
NMT 1.0% |
0.8% |
|
Assay |
98.0% to 99.0% |
99.0% |
